{"name":"Universidad del Desarrollo","slug":"universidad-del-desarrollo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"evaluation of propofol effect using BIS","genericName":"evaluation of propofol effect using BIS","slug":"evaluation-of-propofol-effect-using-bis","indication":"Other","status":"marketed"},{"name":"mRNA vaccine booster","genericName":"mRNA vaccine booster","slug":"mrna-vaccine-booster","indication":"Other","status":"phase_2"},{"name":"propofol targel controlled infusion","genericName":"propofol targel controlled infusion","slug":"propofol-targel-controlled-infusion","indication":"Induction and maintenance of general anesthesia","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Inactivated vaccine booster","genericName":"Inactivated vaccine booster","slug":"inactivated-vaccine-booster","indication":"Prevention of COVID-19","status":"phase_2"}]}],"pipeline":[{"name":"evaluation of propofol effect using BIS","genericName":"evaluation of propofol effect using BIS","slug":"evaluation-of-propofol-effect-using-bis","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Inactivated vaccine booster","genericName":"Inactivated vaccine booster","slug":"inactivated-vaccine-booster","phase":"phase_2","mechanism":"This inactivated vaccine booster works by stimulating the body's immune system to produce a specific response against a particular pathogen.","indications":["Prevention of COVID-19"],"catalyst":""},{"name":"mRNA vaccine booster","genericName":"mRNA vaccine booster","slug":"mrna-vaccine-booster","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"propofol targel controlled infusion","genericName":"propofol targel controlled infusion","slug":"propofol-targel-controlled-infusion","phase":"marketed","mechanism":"Propofol is a short-acting intravenous anesthetic that enhances inhibitory GABA neurotransmission in the central nervous system to produce sedation and anesthesia.","indications":["Induction and maintenance of general anesthesia","Sedation in intensive care units","Sedation for diagnostic and therapeutic procedures"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":2,"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}